Intranasal calcitonin withdrawn owing to cancer risk

Miacalcic Nasal Spray (calcitonin) is being withdrawn owing to an increased risk of cancer with long-term calcitonin use.

by
Calcitonin is no longer licensed for use in osteoporosis, and will only be available as a solution for injection and infusion.  | SCIENCE PHOTO LIBRARY
Calcitonin is no longer licensed for use in osteoporosis, and will only be available as a solution for injection and infusion. | SCIENCE PHOTO LIBRARY

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package